- Home
- SBFM vs DAKT Comparison
SBFM vs DAKT Comparison
Compare SBFM & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- DAKT
- Stock Information
- Founded
- SBFM 2006
- DAKT 1968
- Country
- SBFM United States
- DAKT United States
- Employees
- SBFM N/A
- DAKT N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- DAKT Office Equipment/Supplies/Services
- Sector
- SBFM Health Care
- DAKT Industrials
- Exchange
- SBFM Nasdaq
- DAKT Nasdaq
- Market Cap
- SBFM 7.7M
- DAKT 710.0M
- IPO Year
- SBFM N/A
- DAKT 1994
- Fundamental
- Price
- SBFM $1.65
- DAKT $16.45
- Analyst Decision
- SBFM Strong Buy
- DAKT Strong Buy
- Analyst Count
- SBFM 1
- DAKT 1
- Target Price
- SBFM $15.00
- DAKT $26.00
- AVG Volume (30 Days)
- SBFM 173.3K
- DAKT 475.8K
- Earning Date
- SBFM 08-15-2025
- DAKT 06-25-2025
- Dividend Yield
- SBFM N/A
- DAKT N/A
- EPS Growth
- SBFM N/A
- DAKT N/A
- EPS
- SBFM N/A
- DAKT N/A
- Revenue
- SBFM $36,234,578.00
- DAKT $756,477,000.00
- Revenue This Year
- SBFM $192.48
- DAKT $9.98
- Revenue Next Year
- SBFM N/A
- DAKT $6.80
- P/E Ratio
- SBFM N/A
- DAKT N/A
- Revenue Growth
- SBFM 35.51
- DAKT N/A
- 52 Week Low
- SBFM $1.17
- DAKT $10.24
- 52 Week High
- SBFM $8.03
- DAKT $19.89
- Technical
- Relative Strength Index (RSI)
- SBFM 60.52
- DAKT 66.19
- Support Level
- SBFM $1.39
- DAKT $14.87
- Resistance Level
- SBFM $1.54
- DAKT $16.04
- Average True Range (ATR)
- SBFM 0.12
- DAKT 0.73
- MACD
- SBFM 0.00
- DAKT 0.17
- Stochastic Oscillator
- SBFM 72.22
- DAKT 97.22
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.